IRADIMED CORPORATION (IRMD)
NASDAQ: IRMD · Real-Time Price · USD
94.57
+0.65 (0.69%)
At close: Dec 5, 2025, 4:00 PM EST
94.60
+0.03 (0.03%)
After-hours: Dec 5, 2025, 6:47 PM EST
IRADIMED CORPORATION Market Cap
IRADIMED CORPORATION has a market cap or net worth of $1.20 billion as of December 5, 2025. Its market cap has increased by 85.94% in one year.
Market Cap
1.20B
Enterprise Value
1.15B
1-Year Change
85.94%
Ranking
Category
Stock Price
$94.57
Market Cap Chart
Since July 16, 2014, IRADIMED CORPORATION's market cap has increased from $100.50M to $1.20B, an increase of 1,097.05%. That is a compound annual growth rate of 24.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 1.19B | 71.42% |
| Dec 31, 2024 | 697.00M | 16.48% |
| Dec 29, 2023 | 598.40M | 68.33% |
| Dec 30, 2022 | 355.50M | -37.66% |
| Dec 31, 2021 | 570.30M | 103.90% |
| Dec 31, 2020 | 279.70M | 4.17% |
| Dec 31, 2019 | 268.50M | 0.37% |
| Dec 31, 2018 | 267.50M | 67.29% |
| Dec 29, 2017 | 159.90M | 34.48% |
| Dec 30, 2016 | 118.90M | -61.68% |
| Dec 31, 2015 | 310.30M | 122.44% |
| Dec 31, 2014 | 139.50M | 38.81% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 925.43B |
| Johnson & Johnson | 494.70B |
| AbbVie | 406.92B |
| UnitedHealth Group | 307.72B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 253.84B |
| Thermo Fisher Scientific | 218.08B |